Angiotensin II and AT1 receptor in hypertrophied ventricles and aortas of sinoaortic-denervated rats

Acta Pharmacologica Sinica

Volumn 24, Issue 8, 2003, Pages 812-818

  Miao, Chao Yu ^a   Zhang, Li Ming ^a   Yuan, Wen Jun ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aorta; Arterial baroreflex; Heart; Hypertrophy; Renin angiotensin system; Sinoaortic denervation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; MESSENGER RNA; ANGIOTENSIN II;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART DENERVATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUS NODE; UPREGULATION; ANIMAL; BIOSYNTHESIS; DENERVATION; GENETICS; HEART VENTRICLE; HYPERTROPHY; INNERVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; AORTA; DENERVATION; HEART VENTRICLES; HYPERTROPHY; HYPERTROPHY, LEFT VENTRICULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SINOATRIAL NODE;

EID: 0042567427     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Su DF, Miao CY. Arterial baroreflex function in conscious rats. Acta Pharmacol Sin 2002; 23: 673-9.
2. Miao CY, Su DF. Arterial baroreflex function and left ventricular hypertrophy. Drug Develop Res 2003 (in press)
3. Miao CY, Tao X, Gong K, Zhang SH, Chu ZX, Su DF. Arterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol 2001; 37: 6-15.
4. Miao CY, Su DF. The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation. J Hypertens 2002; 20: 1-8.
5. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 2001; 28: 709-15.
6. Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, et al. Aortic distensibility and structural changes in sinoaortic-denervated rats. Hypertension 1995; 26: 337-40.
7. Van Vliet BN, Hu L, Scott T, Chafe L, Montani JP. Cardiac hypertrophy and telemetered blood pressure 6 wk after baroreceptor denervation in normotensive rats. Am J Physiol 1996; 271: R1759-69.
8. Van Vliet BN, Chafe LL, Montani JP. Contribution of baroreceptors and chemoreceptors to ventricular hypertrophy produced by sino-aortic denervation in rats. J Physiol 1999; 516.3: 885-95.
9. Barres C, Lewis SJ, Jacob HJ, Brody MJ. Arterial pressure lability and renal sympathetic nerve activity are dissociated in SAD rats. Am J Physiol 1992; 263: R639-46.
10. Irigoyen MC, Moreira ED, Ida F, Pires M, Cestari IA, Krieger EM. Changes of renal sympathetic activity in acute and chronic conscious sinoaortic denervated rats. Hypertension 1995; 26: 1111-6.
11. Padilha JU, Krieger EM. Alteration in baroreceptor function in rats produces typical pressure changes during sleep. J Cardiovasc Pharmacol 1987; 10 Suppl 12: S194-8.
12. Alexander N, Morris M. Increased plasma vasopressin in sinoaortic denervated rats. Neuroendocrinology 1986; 42: 361-7.
13. Saavedra JM, Krieger EM. Early increase in adrenomedullary catecholamine synthesis in sinoaortic denervated rats. J Auton Nerv Syst 1987; 18: 181-3.
14. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153: 937-42.
15. Dzau VJ, Gibbons GH. Vascular remodeling: mechanisms and implications. J Cardiovasc Pharmacol 1993; 21 Suppl 1: S1-5.
16. Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one-clip hypertensive rats. J Hypertens 1993; 11: 1347-55.
17. Krieger EM. Neurogenic hypertension in the rat. Circ Res 1964; XV: 511-21.
18. Nishikawa K, Naka T, Chatani F, Yoshimura Y. Candesartan cilexetil: a review of its preclinical pharmacology. J Hum Hypertens 1997; 11 Suppl 2: S9-17.
19. McConnaughey MM, McConnaughey JS, Ingenito AJ. Practical consideration of the pharmacology of angiotensin receptor blockers. J Clin Pharmacol 1999; 39: 547-59.
20. Galinier M, Senard JM, Valet P, Drean G, Planat V, Arias A, et al. Myocardial hypertrophy, cardiac β-adrenoceptors and adenylate cyclase activity during sinoaortic denervation in dogs. Br J Pharmacol 1992; 105: 341-6
21. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 1997; 29: 235-41.
22. Iwai N, Inagami T. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett 1992; 298: 257-60.
23. Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P, et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985; 13: 1431-42.
24. Tea BS, Der Sarkissian S, Touyz RM, Hamet P, deBlois D. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension 2000; 35: 1069-73.
25. Lo M, Julien C, Michel JB, Vincent M, Cerutti C, Gomez-Sanchez CE, et al. Antirenin immunization versus angiotensin converting enzyme inhibition in rats. Hypertension 1990; 16: 80-8.
26. Miao CY, Yuan WJ, Su DF. Comparative study of sinoaortic-denervated rats and spontaneously hypertensive rats. Am J Hypertens (in press)
27. Unger T. Neurohormonal modulation in cardiovascular disease. Am Heart J 2000; 139: S2-8.
28. Leopold JA, Loscalzo J. Clinical importance of understanding vascular biology. Cardiol Rev 2000; 8: 115-23.
29. Bissoli NS, Moyses MR, Vasquez EC, Cabral AM. Captopril prevents ventricular hypertrophy in sinoaortic denervated rats. Braz J Med Biol Res 1991; 24: 191-4
30. Miao CY, Xie HH, Wang JJ, Su DF. Candesartan inhibits sinoaortic denervation-induced cardiovascular hypertrophy in rats. Acta Pharmacol Sin 2002; 23: 713-20.
31. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95: 46-54.
32. Kurabayashi M, Yazaki Y. Downregulation of angiotensin II receptor type 1 in heart failure. A process of adaptation or deterioration? Circulation 1997; 95: 1104-7.
33. 1-receptor subtype in failing human ventricular myocardium. Circulation 1997; 95: 1193-200.